Top news of the week: 16.02.2022.
Companies And Industries
HBCU BioTech Fellowship Program
Amgen + HBCU 20x20 are proud to present the HBCU BioTech Fellowship program. This paid 8-week professional development program will prepare and empower 50 HBCU students (and soon-to-be ...
China's First Biotech M&A Deal In 2022 Signals Busy Season Ahead?
<p><span>CSPC acquires a little-known Guangzhou biotech to kick-start China's pharma sector consolidation in 2022, a key goal outlined in the country's recent 14th Five-Year Plan.</span></p>
Three Big Antibody Research Collabs Hit the Wire
Antibody research on cancer and neurological diseases is prioritized in series of biopharma research agreements.
'I know half of my R&D budget is wasted... The trouble is I don't know which half...'
The quote attributed to John Wanamaker is notorious: “Half the money I spend on advertising is wasted; the trouble is, I don't know which half.” We like the idea that a greater good is ...
Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019
Total raised in public, private and other financings of biopharma companies, comparing 2022 vs. 2021 vs. 2020 vs. 2019.
Curevo will go head-to-head against GSK's Shingrix thanks to new $60M financing
Curevo Vaccine is hoping $60 million in financing will help the small biotech literally go head-to-head against GlaxoSmithKline's market-dominating shingles vaccine Shingrix.
Lilly, Roche Push Back Against CMS Draft Guidance on Aduhelm
CMS says it would only cover the cost of Biogen’s Aduhelm and any required scans “if they are enrolled in qualifying clinical trials.”
SaNOtize, Lupin In Legal Row Concerning COVID-19 Nasal Spray
<p>Canada-based biotech firm SaNOtize and Lupin battle it out in court over alleged breach of confidentiality and copyright infringement in a case concerning their nitric oxide nasal ...